A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study
- PMID: 35668045
- DOI: 10.1002/alz.12700
A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study
Abstract
Introduction: To test the utility of the "A/T/N" system in the Chinese population, we study core Alzheimer's disease (AD) biomarkers in a newly established Chinese cohort.
Methods: A total of 411 participants were selected, including 96 cognitively normal individuals, 94 patients with mild cognitive impairment (MCI) patients, 173 patients with AD, and 48 patients with non-AD dementia. Fluid biomarkers were measured with single molecule array. Amyloid beta (Aβ) deposition was determined by 18F-Flobetapir positron emission tomography (PET), and brain atrophy was quantified using magnetic resonance imaging (MRI).
Results: Aβ42/Aβ40 was decreased, whereas levels of phosphorylated tau (p-tau) were increased in cerebrospinal fluid (CSF) and plasma from patients with AD. CSF Aβ42/Aβ40, CSF p-tau, and plasma p-tau showed a high concordance in discriminating between AD and non-AD dementia or elderly controls. A combination of plasma p-tau, apolipoprotein E (APOE) genotype, and MRI measures accurately predicted amyloid PET status.
Discussion: These results revealed a universal applicability of the "A/T/N" framework in a Chinese population and established an optimal diagnostic model consisting of cost-effective and non-invasive approaches for diagnosing AD.
Keywords: Alzheimer's disease; MRI; amyloid PET; fluid biomarker.
© 2022 the Alzheimer's Association.
References
REFERENCES
-
- Zetterberg H, Bendlin BB. Biomarkers for Alzheimer's disease‐preparing for a new era of disease‐modifying therapies. Mol Psychiatry. 2021;26(1):296‐308. https://doi.org/10.1038/s41380‐020‐0721‐9
-
- Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross‐sectional study. Lancet Public Health. 2020;5(12):e661‐e671. https://doi.org/10.1016/S2468‐2667(20)30185‐7
-
- Jack CR, Jr., Bennett DA, Blennow K, et al. NIA‐AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's Dementia. 2018;14(4):535‐562. https://doi.org/10.1016/j.jalz.2018.02.018
-
- Wu X, Xiao Z, Yi J, et al. Development of a plasma biomarker diagnostic model incorporating ultrasensitive digital immunoassay as a screening strategy for Alzheimer Disease in a Chinese population. Clin Chem. 2021;67(12):1628‐1639. https://doi.org/10.1093/clinchem/hvab192
-
- Mao C, Sha L, Li J, et al. Relationship between general cognition, visual assessed cortical atrophy, and cerebrospinal fluid biomarkers in Alzheimer's disease: a cross‐sectional study from a Chinese PUMCH cohort. J Alzheimers Dis. 2021;82(1):205‐214. https://doi.org/10.3233/JAD‐210344
Publication types
MeSH terms
Substances
Grants and funding
- 2020YFA0509304/National Key Plan for Scientific Research and Development of China
- 2021YFA0805300/National Key Plan for Scientific Research and Development of China
- XDB39000000/Chinese Academy of Sciences
- 31530089/National Natural Sciences Foundation of China
- 82030034/National Natural Sciences Foundation of China
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
